Tag: Frontiers in Pharmacology

Study: CBD May Treat Psychiatric/Cognitive Symptoms Associated with Neurodegeneration

Cannabidiol (CBD) may be beneficial in the treatment of psychiatric/cognitive symptoms associated with neurodegeneration, according to a new study. The study, published by the journal Frontiers in Pharmacology, was also published online by the U.S. National Institute of Health. “Beneficial effects of cannabidiol (CBD) have been described for a wide range of psychiatric disorders, including …

Continue reading

Study: Cannabis Improves Cognitive Performance, Reduces Prescription Drug Use

By Paul Armentano, NORML Medical cannabis administration is associated with improved cognitive performance and lower levels of prescription drug use, according to longitudinal data published online in the journal Frontiers in Pharmacology. Investigators from Harvard Medical School, Tufts University, and McLean Hospital evaluated cannabis on patients’ cognitive performance over a three-month period. Participants in the …

Continue reading

New Study: Cannabis May Treat Schizophrenia

A new study published in this month’s issue of the journal Frontiers in Pharmacology, and published online by the National Institute of Health, has found that cannabis may treat schizophrenia. “Clinical and neurobiological findings suggest that the cannabinoids and the endocannabinoid system may be implicated in the pathophysiology and treatment of schizophrenia”, begins the study’s abstract. “We …

Continue reading